HOTH Hoth Therapeutics, Inc.
Healthcare$0.71+2.65%ClosedMarket Cap: $9.4M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.62
P/S
0.00
EV/EBITDA
-0.44
DCF Value
$0.40
FCF Yield
-110.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-165.2%
ROA
-208.9%
ROIC
-277.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-2.6M | $-2.7M | $— | — |
| Q4 null | $0.00 | NaN% | $-2.6M | $-2.7M | $— | — |
| FY null | $0.00 | NaN% | $-11.1M | $-12.5M | $— | — |
| Q3 null | $0.00 | NaN% | $-4.1M | $-4.1M | $— | — |
| Q2 null | $0.00 | NaN% | $-2.2M | $-2.2M | $— | — |
| Q1 null | $0.00 | NaN% | $-3.5M | $-3.5M | $— | — |
| Q4 null | $0.00 | NaN% | $-2.4M | $-2.4M | $— | — |
| FY null | $0.00 | NaN% | $-8.2M | $-8.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-2.1M | $-2.1M | $— | — |
| Q2 null | $0.00 | NaN% | $-1.6M | $-1.6M | $— | — |
| Q1 null | $0.00 | NaN% | $-2.2M | $-2.1M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-1.7M | $-1.7M | $-0.39 | — |